PTEN and prostate carcinoma: The current transgenic model of Pten is widely used in the study of tumorigenesis mechanisms; however, half of the Pten knockout mice died within 1 year after birth, and the rest developed a variety of tumors, including lung, breast, thyroid, endometrial, and prostate cancer, and T-cell lymphoma (98).